A single-centre analysis of 30 patients with relapsed germ cell tumours treated with the TI-CE regimen

Bone Marrow Transplant. 2016 Jun;51(6):856-9. doi: 10.1038/bmt.2015.354. Epub 2016 Feb 8.

Authors

G O'Kane¹, D Bracken-Clarke², N Gardiner², G Lee², M Ni Chonghaile², D Power³, P A Daly¹, J McCaffrey⁴, C L Bacon², E Conneally², C Flynn², E Vandenberghe², M J Kennedy¹, P V Browne², D M O'Donnell¹, P J Hayden²

Affiliations

¹ Department of Medical Oncology, St. James's Hospital, Dublin, Ireland.
² Academic Department of Haematology, Trinity College Dublin, St. James's Hospital, Dublin, Ireland.
³ Department of Medical Oncology, Cork University Hospital, Cork, Ireland.
⁴ Department of Medical Oncology, Mater Misericordiae Hospital, Dublin, Ireland.

PMID: 26855151
DOI: 10.1038/bmt.2015.354

No abstract available

MeSH terms

Adolescent
Adult
Antineoplastic Agents / therapeutic use*
Antineoplastic Combined Chemotherapy Protocols / therapeutic use*
Carboplatin / administration & dosage
Etoposide / administration & dosage
Follow-Up Studies
Humans
Ifosfamide / administration & dosage
Male
Middle Aged
Neoplasm Metastasis
Neoplasm Recurrence, Local
Neoplasms, Germ Cell and Embryonal / therapy*
Paclitaxel / administration & dosage
Prognosis
Prospective Studies
Retrospective Studies
Salvage Therapy*
Time Factors
Treatment Outcome
Young Adult

Substances

Antineoplastic Agents
Etoposide
Carboplatin
Paclitaxel
Ifosfamide